Chenguang Biotech Group
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more
Market Cap & Net Worth: Chenguang Biotech Group (300138)
Chenguang Biotech Group (SHE:300138) has a market capitalization of $911.91 Million (CN¥6.69 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #9182 globally and #1849 in its home market, demonstrating a -4.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Chenguang Biotech Group's stock price CN¥13.85 by its total outstanding shares 483100093 (483.10 Million).
Chenguang Biotech Group Market Cap History: 2015 to 2026
Chenguang Biotech Group's market capitalization history from 2015 to 2026. Data shows growth from $501.03 Million to $911.91 Million (8.77% CAGR).
Chenguang Biotech Group Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Chenguang Biotech Group's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.08x
Chenguang Biotech Group's market cap is 0.08 times its annual revenue
0.16x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
6.10x
Chenguang Biotech Group's market cap is 6.10 times its annual earnings
7.56x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $501.03 Million | $1.27 Billion | $68.86 Million | 0.40x | 7.28x |
| 2016 | $515.70 Million | $2.14 Billion | $92.47 Million | 0.24x | 5.58x |
| 2017 | $504.35 Million | $2.77 Billion | $142.83 Million | 0.18x | 3.53x |
| 2018 | $323.27 Million | $3.06 Billion | $145.28 Million | 0.11x | 2.23x |
| 2019 | $471.54 Million | $3.27 Billion | $193.57 Million | 0.14x | 2.44x |
| 2020 | $1.21 Billion | $3.91 Billion | $267.74 Million | 0.31x | 4.53x |
| 2021 | $1.06 Billion | $4.87 Billion | $351.51 Million | 0.22x | 3.03x |
| 2022 | $1.14 Billion | $6.30 Billion | $434.03 Million | 0.18x | 2.63x |
| 2023 | $871.07 Million | $6.87 Billion | $479.72 Million | 0.13x | 1.82x |
| 2024 | $574.14 Million | $6.99 Billion | $94.05 Million | 0.08x | 6.10x |
Competitor Companies of 300138 by Market Capitalization
Companies near Chenguang Biotech Group in the global market cap rankings as of March 19, 2026.
Key companies related to Chenguang Biotech Group by market ranking:
- Archer-Daniels-Midland Company (NYSE:ADM): Ranked #624 globally with a market cap of $33.40 Billion USD.
- Bunge Limited (NYSE:BG): Ranked #977 globally with a market cap of $20.06 Billion USD.
- Tyson Foods Inc (NYSE:TSN): Ranked #1129 globally with a market cap of $17.12 Billion USD.
- Muyuan Foodstuff Co Ltd (SHE:002714): Ranked #1187 globally with a market cap of $15.81 Billion USD ( CN¥116.00 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #624 | Archer-Daniels-Midland Company | NYSE:ADM | $33.40 Billion | $72.12 |
| #977 | Bunge Limited | NYSE:BG | $20.06 Billion | $125.96 |
| #1129 | Tyson Foods Inc | NYSE:TSN | $17.12 Billion | $62.07 |
| #1187 | Muyuan Foodstuff Co Ltd | SHE:002714 | $15.81 Billion | CN¥50.24 |
Chenguang Biotech Group Historical Marketcap From 2015 to 2026
Between 2015 and today, Chenguang Biotech Group's market cap moved from $501.03 Million to $ 911.91 Million, with a yearly change of 8.77%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥911.91 Million | +11.60% |
| 2025 | CN¥817.10 Million | +42.32% |
| 2024 | CN¥574.14 Million | -34.09% |
| 2023 | CN¥871.07 Million | -23.57% |
| 2022 | CN¥1.14 Billion | +7.03% |
| 2021 | CN¥1.06 Billion | -12.20% |
| 2020 | CN¥1.21 Billion | +157.18% |
| 2019 | CN¥471.54 Million | +45.87% |
| 2018 | CN¥323.27 Million | -35.90% |
| 2017 | CN¥504.35 Million | -2.20% |
| 2016 | CN¥515.70 Million | +2.93% |
| 2015 | CN¥501.03 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Chenguang Biotech Group was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $911.91 Million USD |
| MoneyControl | $911.91 Million USD |
| MarketWatch | $911.91 Million USD |
| marketcap.company | $911.91 Million USD |
| Reuters | $911.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.